chr10-3103861-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002627.5(PFKP):c.537C>T(p.Cys179Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000773 in 1,613,958 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00059 ( 2 hom. )
Consequence
PFKP
NM_002627.5 synonymous
NM_002627.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.104
Publications
1 publications found
Genes affected
PFKP (HGNC:8878): (phosphofructokinase, platelet) This gene encodes a member of the phosphofructokinase A protein family. The encoded enzyme is the platelet-specific isoform of phosphofructokinase and plays a key role in glycolysis regulation. This gene may play a role in metabolic reprogramming in some cancers, including clear cell renal cell carcinomas, and cancer of the bladder, breast, and lung. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 10-3103861-C-T is Benign according to our data. Variant chr10-3103861-C-T is described in ClinVar as Benign. ClinVar VariationId is 735159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.104 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00254 AC: 386AN: 152170Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
386
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000871 AC: 219AN: 251332 AF XY: 0.000765 show subpopulations
GnomAD2 exomes
AF:
AC:
219
AN:
251332
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000588 AC: 859AN: 1461672Hom.: 2 Cov.: 33 AF XY: 0.000557 AC XY: 405AN XY: 727148 show subpopulations
GnomAD4 exome
AF:
AC:
859
AN:
1461672
Hom.:
Cov.:
33
AF XY:
AC XY:
405
AN XY:
727148
show subpopulations
African (AFR)
AF:
AC:
229
AN:
33480
American (AMR)
AF:
AC:
29
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
26136
East Asian (EAS)
AF:
AC:
6
AN:
39700
South Asian (SAS)
AF:
AC:
5
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53250
Middle Eastern (MID)
AF:
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
527
AN:
1111966
Other (OTH)
AF:
AC:
57
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
44
88
133
177
221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00255 AC: 388AN: 152286Hom.: 1 Cov.: 33 AF XY: 0.00265 AC XY: 197AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
388
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
197
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
330
AN:
41558
American (AMR)
AF:
AC:
15
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
2
AN:
5166
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
38
AN:
68030
Other (OTH)
AF:
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 23, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.